AARD · Aardvark Therapeutics
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
4370 La Jolla Village Drive, San Diego, CA, 92122, United States
Biotechnology
Healthcare
Market Cap
115.3M
52 Wk Range
$3.35 - $17.94
Previous Close
$5.27
Open
$5.21
Volume
39,897
Day Range
$5.00 - $5.39
Enterprise Value
48.49M
Cash
73.87M
Avg Qtr Burn
-17.6M
Insider Ownership
15.77%
Institutional Own.
52.58%
Qtr Updated
Jun 30th 2026